Correspondence | Published:

The origins of new drugs

Subjects

  • A Corrigendum to this article was published on 01 August 2005

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Cockburn, I. & Henderson, R. Public-Private Interaction and the Productivity of Pharmaceutical Research. National Bureau of Economic Research (NBER) Working Paper 6018 (NBER, Cambridge, MA, 1997).

  2. 2

    Powell, W.W., Korput, K.W. & Smith-Doerr, L. Administr. Sci. Quart. 41, 116–145 (1996).

  3. 3

    Murray, F. Res. Policy 31, 1389–1403 (2002).

  4. 4

    Henderson, R., Orsenigo, L. & Pisano, G.P. in Sources of Industrial Leadership, Studies of Seven Industries (eds. Mowery, D. & Nelson, R.) 267–311 (Cambridge University Press, Cambridge, UK, 1999).

  5. 5

    McKelvey, M. Evolutionary Innovations, the Business of Biotechnology (Oxford University Press, Oxford, 1996).

  6. 6

    Zucker, L.G. & Darby, M.R. Proc. Natl. Acad. Sci. USA 93, 12709–12716 (1996).

Download references

Author information

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article

Further reading